NO20090128L - Salter av N-hydroksy-3-[4-[[[2-(2-metyl-1H-indol-3-yl)etyl]amino]metyl]fenyl]-2E-2-propenamid - Google Patents

Salter av N-hydroksy-3-[4-[[[2-(2-metyl-1H-indol-3-yl)etyl]amino]metyl]fenyl]-2E-2-propenamid

Info

Publication number
NO20090128L
NO20090128L NO20090128A NO20090128A NO20090128L NO 20090128 L NO20090128 L NO 20090128L NO 20090128 A NO20090128 A NO 20090128A NO 20090128 A NO20090128 A NO 20090128A NO 20090128 L NO20090128 L NO 20090128L
Authority
NO
Norway
Prior art keywords
methyl
propenamide
indol
hydroxy
phenyl
Prior art date
Application number
NO20090128A
Other languages
English (en)
Other versions
NO341871B1 (no
Inventor
Murat Acemogulu
Joel Slade
Piotr Karpinski
Dimitris Papoutsakis
Joginder S Bajwa
Frank Stowasser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38564366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090128(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20090128L publication Critical patent/NO20090128L/no
Publication of NO341871B1 publication Critical patent/NO341871B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Salter av N-hydroksy-3-[4-[[[2-(2-metyl-lH-indol-3-yl)etyl]amino]metyl]fenyl]-2E-2-propenamid er fremstilt og karakterisert.
NO20090128A 2006-06-12 2009-01-09 Salter av N-hydroksy-3-[4-[[[2-(2-metyl-1H-indol-3-yl)etyl]amino]metyl]fenyl]-2E-2-propenamid NO341871B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80452306P 2006-06-12 2006-06-12
US86999306P 2006-12-14 2006-12-14
PCT/US2007/070558 WO2007146715A1 (en) 2006-06-12 2007-06-07 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide

Publications (2)

Publication Number Publication Date
NO20090128L true NO20090128L (no) 2009-03-11
NO341871B1 NO341871B1 (no) 2018-02-12

Family

ID=38564366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090128A NO341871B1 (no) 2006-06-12 2009-01-09 Salter av N-hydroksy-3-[4-[[[2-(2-metyl-1H-indol-3-yl)etyl]amino]metyl]fenyl]-2E-2-propenamid

Country Status (37)

Country Link
US (3) US20090197936A1 (no)
EP (1) EP2032531B1 (no)
JP (2) JP2009540005A (no)
KR (2) KR101629352B1 (no)
AR (1) AR061298A1 (no)
AU (1) AU2007257962B2 (no)
BR (1) BRPI0712771A2 (no)
CA (1) CA2654439C (no)
CL (1) CL2007001692A1 (no)
CR (1) CR10439A (no)
DK (1) DK2032531T3 (no)
EA (1) EA015212B1 (no)
EC (1) ECSP088979A (no)
ES (1) ES2570934T3 (no)
GE (1) GEP20105125B (no)
GT (1) GT200800279A (no)
HN (1) HN2008001859A (no)
HR (1) HRP20160291T1 (no)
HU (1) HUE027126T2 (no)
IL (1) IL195087A (no)
JO (1) JO3138B1 (no)
MA (1) MA30563B1 (no)
ME (1) ME00531B (no)
MX (1) MX2008015901A (no)
MY (1) MY147345A (no)
NO (1) NO341871B1 (no)
NZ (1) NZ572547A (no)
PE (1) PE20080937A1 (no)
PL (1) PL2032531T3 (no)
RS (1) RS54640B1 (no)
SI (1) SI2032531T1 (no)
SM (1) SMP200900002B (no)
SV (1) SV2008003126A (no)
TN (1) TNSN08501A1 (no)
TW (1) TWI409254B (no)
UY (1) UY30403A1 (no)
WO (1) WO2007146715A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090015968A (ko) 2006-06-12 2009-02-12 노파르티스 아게 Ｎ-히드록시-3-[4-[[[2-(2-메틸-1ｈ-인돌-3-일)에틸]아미노]메틸]페닐]-2ｅ-2-프로펜아미드의 동질이상체
KR20090098920A (ko) * 2007-01-10 2009-09-17 노파르티스 아게 데아세틸라제 억제제의 제제
US8519002B2 (en) 2008-04-07 2013-08-27 Takeda Pharmaceuticals U.S.A., Inc. Colchicine solid complex; methods of making; and methods of use thereof
US8003700B2 (en) 2008-04-07 2011-08-23 Mutual Pharamaceutical Company, Inc. Colchicine solid complex; methods of making; and methods of use thereof
UY32297A (es) * 2008-12-22 2010-05-31 Almirall Sa Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
JP5263211B2 (ja) 2010-03-30 2013-08-14 ブラザー工業株式会社 サーバ、プリンタ、及び、サーバのためのコンピュータプログラム
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
MA41544A (fr) 2015-02-19 2017-12-26 Novartis Ag Dosages de panobinostat pour le traitement du myélome multiple
WO2017221163A1 (en) * 2016-06-21 2017-12-28 Alembic Pharmaceuticals Limited Novel salts and polymorphic forms of panobinostat
US12220569B2 (en) 2020-03-25 2025-02-11 Boston Scientific Scimed, Inc. Medical device for treating decompensated heart failure
PE20230110A1 (es) 2020-04-30 2023-01-25 Exelixis Inc Procesos para la preparacion de un inhibidor de cinasa
TW202233595A (zh) * 2020-10-28 2022-09-01 美商維拉克塔股份有限公司 Ｈｄａｃ抑制劑固態形式

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
US20060270730A1 (en) * 2003-08-07 2006-11-30 Andreas Katopodis Histone deacetylase inhibitors as immunosuppressants
US20050228300A1 (en) * 2004-04-07 2005-10-13 Triage Data Networks Cuffless blood-pressure monitor and accompanying wireless mobile device
RU2008151724A (ru) * 2006-06-12 2010-07-20 Новартис АГ (CH) Способ получения солей n-гидрокси-3-[4-[[[2-(2-метил-1н-индол-3-ил)этил]амино]метил]фенил]-2е-2-пропенамида
KR20090015968A (ko) * 2006-06-12 2009-02-12 노파르티스 아게 Ｎ-히드록시-3-[4-[[[2-(2-메틸-1ｈ-인돌-3-일)에틸]아미노]메틸]페닐]-2ｅ-2-프로펜아미드의 동질이상체

Also Published As

Publication number Publication date
TW200815343A (en) 2008-04-01
PL2032531T3 (pl) 2016-07-29
TWI409254B (zh) 2013-09-21
MY147345A (en) 2012-11-30
EA015212B1 (ru) 2011-06-30
PE20080937A1 (es) 2008-08-29
HUE027126T2 (en) 2016-08-29
JP2009540005A (ja) 2009-11-19
EP2032531B1 (en) 2016-02-10
KR20150029765A (ko) 2015-03-18
UY30403A1 (es) 2008-01-31
HN2008001859A (es) 2011-07-19
RS54640B1 (sr) 2016-08-31
MA30563B1 (fr) 2009-07-01
SV2008003126A (es) 2011-07-05
CA2654439C (en) 2014-08-05
GEP20105125B (en) 2010-11-25
WO2007146715A1 (en) 2007-12-21
EP2032531A1 (en) 2009-03-11
SI2032531T1 (sl) 2016-05-31
NZ572547A (en) 2011-06-30
AR061298A1 (es) 2008-08-20
CA2654439A1 (en) 2007-12-21
US20110112308A1 (en) 2011-05-12
ECSP088979A (es) 2009-01-30
IL195087A (en) 2012-10-31
TNSN08501A1 (en) 2010-04-14
AU2007257962B2 (en) 2011-06-23
CL2007001692A1 (es) 2008-05-09
EA200802382A1 (ru) 2009-06-30
NO341871B1 (no) 2018-02-12
BRPI0712771A2 (pt) 2012-09-25
JP5771257B2 (ja) 2015-08-26
JP2013256542A (ja) 2013-12-26
IL195087A0 (en) 2009-08-03
JO3138B1 (ar) 2017-09-20
US20090197936A1 (en) 2009-08-06
US20100286409A1 (en) 2010-11-11
HRP20160291T1 (hr) 2016-04-22
CR10439A (es) 2009-01-15
ME00531B (me) 2011-10-10
KR20090026281A (ko) 2009-03-12
ES2570934T3 (es) 2016-05-23
MX2008015901A (es) 2009-01-12
SMAP200900002A (it) 2009-01-14
SMP200900002B (it) 2010-01-19
KR101629352B1 (ko) 2016-06-13
DK2032531T3 (en) 2016-04-11
HK1126496A1 (zh) 2009-09-04
AU2007257962A1 (en) 2007-12-21
GT200800279A (es) 2010-06-16

Similar Documents

Publication Publication Date Title
JO3138B1 (ar) املاح n- هيدروكسي -3- [4-[[[2-(2-مثيل-h1-اندول -3-يل)ايثيل]امينو]مثيل]فنيل]-e2-2-بروبيناميد
NO20090135L (no) Polymorfer av N-hydroksy-3-[4-[[[-(2-metyl-1H-indol-3-yl)etyl]amino]metyl]fenyl]2E-2-propenamid
NO20090136L (no) Fremgangsmate for fremstilling av salter av N-hydroksy-3-[4-[[[2-(2-metyl-1H-1ln-dol-3-yl)etyl]amino]metyl]fenyl]-2E-2-propenamid
UA95289C2 (en) Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
UA97243C2 (en) Crystalline anhydrous form of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
CY1117493T1 (el) Αλατα του ν-υδροξυ-3-[4-[[[2-(2-μεθυλ-1η-ινδολ-3-υλ)αιθυλ]αμινο]μεθυλο]φαινυλο]-2ε-2-προπεναμιδιου
IL233836A0 (en) Method for preparing n-hydroxy-3-[4-[[[2-(2-methyl-h1-indol-3-yl)ethyl]amino]methyl]phenyl]-e2-2-propanamide
DOP2008000069A (es) Sales de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]]fenil]-2e-2-propenamida.
HK1132509A (en) Polymorphs of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SECURA BIO, US

MM1K Lapsed by not paying the annual fees